- Article
Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs
- Kevin Delgado-Calvo,
- Elisa Lozano,
- Oscar Briz,
- Candela Cives-Losada,
- Jose J. G. Marin and
- Rocio I. R. Macias
The pharmacological treatment of cholangiocarcinoma (CCA) is often hampered by tumor resistance. Improving our understanding of this issue is crucial for developing strategies that can overcome drug refractoriness. We have established and characteriz...

